Stocklytics Platform
Asset logo for symbol CERE
Cerevel Therapeutics Holdings
CERE40
$44.960.00%$0.00
Asset logo for symbol CERE
CERE40

$44.96

0.00%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Cerevel Therapeutics Holdings (CERE) Stocklytics Forecast

Cerevel Therapeutics Holdings, Inc. (CERE) is a biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for neurological disorders. With a strong pipeline of potential treatments, CERE has garnered attention from investors who are looking for promising growth opportunities in the healthcare sector.
When it comes to predicting the stock price of CERE, there are several factors that need to be considered. One approach is to look at AI-based price predictions. Advanced algorithms and machine learning models can analyze historical data, market trends, and other relevant factors to make forecasts. While these predictions can provide valuable insights, it's important to remember that they are not guaranteed and should be used as one tool among many in making investment decisions.
add Cerevel Therapeutics Holdings to watchlist

Keep an eye on Cerevel Therapeutics Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Cerevel Therapeutics Holdings (CERE) stock?

Analysts have set a target price of $36.74 for Cerevel Therapeutics Holdings (CERE), based on forecasts from 27 analysts. The predicted price range extends from a high of $48 to a low of $22. This represents a potential increase of up to 6.76% and a decrease of -51.07% from the current price of $44.96. These forecasts are as of 2022 Nov 09.
help

What are the analyst ratings for Cerevel Therapeutics Holdings (CERE) stock?

Currently, there are no analyst ratings available for Cerevel Therapeutics Holdings (CERE), possibly due to insufficient coverage or recent updates.
help

What is the AI price prediction for Cerevel Therapeutics Holdings (CERE) stock?

At present, there is no AI or machine-learning-based price prediction available for Cerevel Therapeutics Holdings (CERE) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level